Quarterly report pursuant to Section 13 or 15(d)

Net loss per share (Tables)

v3.23.2
Net loss per share (Tables)
6 Months Ended
Jun. 30, 2023
Net loss per share [Abstract]  
Anti-dilutive Securities Excluded from Computation of Net Loss per Share
The following potential common shares were not considered in the computation of diluted net loss per share as their effect would have been anti-dilutive for the three and six-month periods presented below:
 
   
June 30,
 
   
2023
   
2022
 
Series A, Series B, and RDO warrants
   
7,204,299
     
7,283,000
 
Stock options
   
3,444,656
     
2,784,544
 
RSUs     282,008        
Unissued common stock for services
   
     
14,147
 
Former Rexahn warrants
   
58,597
     
63,734